6254 Participants Needed

Blood Pressure Management During Surgery for High Blood Pressure

Recruiting at 15 trial locations
RJ
FR
Overseen ByFabio Rodriguez Patarroyo, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
Must be taking: Antihypertensives
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The treatments will be: 1) norepinephrine or phenylephrine infusion to maintain intraoperative MAP ≥85 mmHg (tight pressure management); or, 2) routine intraoperative blood pressure management (routine pressure management).

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does require that you are already taking at least one medication for high blood pressure. It's best to discuss this with the trial team or your doctor.

What data supports the effectiveness of blood pressure management treatments during surgery for high blood pressure?

Research suggests that managing blood pressure during and after surgery is crucial to prevent complications. Continuing antihypertensive therapy (medications to lower blood pressure) up to the day of surgery and maintaining blood pressure below certain levels before surgery can reduce surgical risks.12345

Is blood pressure management during surgery safe for humans?

Blood pressure management during surgery is generally considered safe when carefully monitored, as seen in the use of clevidipine for controlling blood pressure in both adults and children during surgery. However, continuous monitoring and appropriate drug selection are crucial to avoid complications.46789

How does the blood pressure management treatment during surgery differ from other treatments?

This treatment is unique because it involves tight control of blood pressure during surgery using specific medications like norepinephrine and phenylephrine, which are vasopressors (drugs that tighten blood vessels to raise blood pressure). This approach is more intensive compared to standard management and aims to maintain stable blood pressure, reducing the risk of complications during and after surgery.34101112

Research Team

DI

Daniel I Sessler, MD

Principal Investigator

The Cleveland Clinic

Eligibility Criteria

The GUARDIAN Trial is for adults over 45 with high blood pressure who are taking medication for it and scheduled for major noncardiac surgery lasting at least 2 hours. They must be hospitalized overnight, have a certain level of systemic disease, direct blood pressure monitoring during surgery, and one additional risk factor like heart disease or diabetes. Exclusions include those needing organ transplants or specific surgeries, contraindications to the study drugs, or cognitive impairments.

Inclusion Criteria

I expect to stay in the hospital overnight or longer.
I am scheduled for a major surgery that is not heart-related and will last at least 2 hours.
I have a serious health condition that affects my daily life.
See 6 more

Exclusion Criteria

I am scheduled for brain surgery.
I need medicine through an IV to help control my blood pressure before surgery.
I need to be seated in a beach-chair position for my procedure.
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either tight or routine intraoperative blood pressure management during surgery

During surgery

Postoperative Monitoring

Participants are monitored for major perfusion-related complications and other outcomes

30 days

Follow-up

Participants are monitored for cognition and major adverse cardiac events

1 year

Treatment Details

Interventions

  • Routine pressure management
  • Tight pressure management
  • Vasopressor
Trial OverviewThis trial tests two ways to manage blood pressure during major surgery: 'tight' management aims to keep intraoperative mean arterial pressure (MAP) ≥85 mmHg using norepinephrine or phenylephrine infusions; 'routine' management follows standard care without this strict MAP target.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Tight pressure managementExperimental Treatment1 Intervention
In patients assigned to tight blood pressure control, angiotensin converting enzyme inhibitors and angiotensin receptor blockers will not be given the morning of surgery. Other chronic antihypertensives will only be given as necessary to treat hypertension. Norepinephrine or phenylephrine infusion will be infused at a rate sufficient to maintain intraoperative MAP ≥ 85 mmHg.
Group II: Routine pressure managementExperimental Treatment1 Intervention
ACEIs, ARBs, and/or calcium channel blockers can be given the morning of surgery if deemed appropriate by the attending anesthesiologist. Intraoperative blood pressure will be managed per clinical routine.

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+

Findings from Research

Intra-arterial blood pressure monitoring in 4342 patients undergoing noncardiac surgery was associated with a higher incidence of peri-operative myocardial injury (38.7%) compared to noninvasive monitoring (25.7%), indicating a potential increased risk of morbidity.
Even after adjusting for various patient and surgical factors, intra-arterial monitoring remained linked to a greater risk of myocardial injury, suggesting that this method may not improve outcomes and could warrant further investigation in future studies.
Mode of blood pressure monitoring and morbidity after noncardiac surgery: A prospective multicentre observational cohort study.Abbott, TEF., Howell, S., Pearse, RM., et al.[2023]
Perioperative hypertension is a common issue during surgery, but there is no standardized method for assessing intraoperative hemodynamics, leading to variability in treatment approaches.
Management of perioperative hypertension should be tailored to each patient, as there is no consensus on treatment thresholds or targets, highlighting the need for individualized therapy.
Perioperative hypertension management.Varon, J., Marik, PE.[2022]
Postoperative hypotension is common in ICU patients after noncardiac surgery and is linked to serious complications such as myocardial infarction, acute kidney injury, and even death, suggesting it may be a modifiable risk factor.
Despite the association between hypotension and adverse outcomes, there is still insufficient evidence to confirm a direct causal relationship, highlighting the need for further research to determine if managing blood pressure can improve postoperative results.
Postoperative blood pressure management in patients treated in the ICU after noncardiac surgery.Briesenick, L., Flick, M., Saugel, B.[2021]

References

Mode of blood pressure monitoring and morbidity after noncardiac surgery: A prospective multicentre observational cohort study. [2023]
Perioperative hypertension management. [2022]
Postoperative blood pressure management in patients treated in the ICU after noncardiac surgery. [2021]
[Hypertension and surgical risk]. [2007]
Perioperative hypertension. The primary care physician's role. [2019]
Nonprescription drugs and hypertension. Which ones affect blood pressure? [2019]
Perioperative Hypertension Management during Facelift under Local Anesthesia with Intravenous Hypnotics. [2020]
Novel Use of Clevidipine for Intraoperative Blood Pressure Management in Patients With Pheochromocytoma. [2019]
Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Strategies for managing perioperative hypertension. [2008]
11.United Statespubmed.ncbi.nlm.nih.gov
Periprocedural hypertension: current concepts in management for the vascular surgeon. [2017]
Circulatory changes during and after surgical anesthesia in hypertensive patients treated with clonidine, methyldopa and reserpine. [2013]